Hearing Benefits of Clinical Management for Meniere's Disease

被引:1
|
作者
Zhang, Yi [1 ,2 ]
Wei, Chenyi [1 ,2 ]
Sun, Zhengtao [1 ,2 ]
Wu, Yue [1 ,2 ]
Chen, Zhengli [1 ,2 ]
Liu, Bo [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China
[2] Minist Educ, Beijing Inst Otolaryngol, Key Lab Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China
关键词
Meniere's disease; sensorineural hearing loss; clinical management; pure-tone audiometry; FLUCTUATION; GUIDELINES; EVOLUTION; SYMPTOMS; EAR;
D O I
10.3390/jcm11113131
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Meniere's disease is a progressive hearing-disabling condition. Patients can benefit from strict clinical management, including lifestyle and dietary counseling, and medical treatment. A prospective cohort study was carried out with 154 patients with definite Meniere's disease, with an average age of 43.53 +/- 11.40, and a male to female ratio of 0.97:1. The pure-tone thresholds of all 165 affected ears, over a one-year clinical management period, were analyzed. After one year, 87.27% of patients had improved or preserved their hearing at a low frequency, and 71.51% at a high frequency. The hearing threshold at frequencies from 250 Hz to 2000 Hz had improved significantly (p < 0.001, p < 0.001, p < 0.001, p < 0.01), and deteriorated slightly at 8000 Hz (p < 0.05). Of all the patients, 40.00% had a hearing average threshold that reached <= 25 dB HL after the clinical management period, among whom 27.27% were patients in stage 3. The restoration time was 2.5 (1.0, 4.125) months, with a range of 0.5-11.0 months, and the restoration time was longer for stage 3 than for stages 1 and 2 (u = -2.542, p < 0.05). The rising curves improved the most (p < 0.05), with most becoming peaks, whereas most peaks and flats remained the same. Patients who were initially in the earlier stages (95% CI 1.710 similar to 4.717, OR 2.840, p < 0.001), have an increased odds ratio of hearing by an average of <= 25 dB HL. Age (95% CI 1.003 similar to 1.074, OR 1.038, p = 0.031), peak curve (95% CI 1.038 similar to 5.945, OR = 2.484, p = 0.041), and flat curve (95% CI 1.056 similar to 19.590, OR = 4.549, p = 0.042), compared with the rising curve, increase the odds ratio of hearing on average by >25 dB HL. Most patients can have their hearing preserved or improved through strict clinical management, and sufficient follow-up is also essential. Stage 3 patients also have the potential for hearing improvement, although the restoration time is longer than in the early stages. The initial hearing stage, age, and audiogram pattern are related to the hearing benefits.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] MENIERE'S DISEASE Meniere's disease and the DVLA
    Henderson, Arthur
    Waddell, A.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [32] Clinical characteristics of tinnitus in Meniere's disease
    Romero Sanchez, Iballa
    Perez Garrigues, Herminio
    Rodriguez Rivera, Veronica
    [J]. ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2010, 61 (05): : 327 - 331
  • [33] Clinical Practice Guideline: Meniere's Disease
    Basura, Gregory J.
    Adams, Meredith E.
    Monfared, Ashkan
    Schwartz, Seth R.
    Antonelli, Patrick J.
    Burkard, Robert
    Bush, Matthew L.
    Bykowski, Julie
    Colandrea, Maria
    Derebery, Jennifer
    Kelly, Elizabeth A.
    Kerber, Kevin A.
    Koopman, Charles F.
    Kuch, Amy Angie
    Marcolini, Evie
    McKinnon, Brian J.
    Ruckenstein, Michael J.
    Valenzuela, Carla V.
    Vosooney, Alexis
    Walsh, Sandra A.
    Nnacheta, Lorraine C.
    Dhepyasuwan, Nui
    Buchanan, Erin M.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2020, 162 (2_SUPPL) : S1 - S55
  • [34] Hearing results following intratympanic gentamicin perfusion for Meniere's disease
    Kyrodimos, E.
    Aidonis, I.
    Sismanis, A.
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2009, 123 (04): : 379 - 382
  • [35] Prognostic Implications of and Audiometric Evidence for Hearing Fluctuation in Meniere's Disease
    Hoa, Michael
    Friedman, Rick A.
    Fisher, Laurel M.
    Derebery, M. Jennifer
    [J]. LARYNGOSCOPE, 2015, 125 : S1 - S12
  • [36] Hearing function after betahistine therapy in patients with Meniere's disease
    Tootoonchi, Seyed Javad Seyed
    Ghiasi, Samad
    Shadara, Parvaneh
    Samani, Simin Mirakhor
    Fouladi, Daniel Fadaei
    [J]. BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2016, 82 (05) : 500 - 506
  • [37] Intratympanic gentamicin treatment of patients with Meniere's disease with normal hearing
    Silverstein, Herbert
    Wazen, Jack
    Van Ess, Mark J.
    Daugherty, Julie
    Alameda, Yadiel A.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2010, 142 (04) : 570 - 575
  • [38] A Portrait of Meniere's Disease Using Contemporary Hearing and Balance Tests
    Hannigan, Imelda P.
    Rosengren, Sally M.
    Young, Allison S.
    Bradshaw, Andrew P.
    Calic, Zeljka
    Kwok, Belinda
    Alraddy, Bashayer
    Gibson, William P. R.
    Kong, Jonathan
    Flanagan, Sean
    Halmagyi, G. Michael
    Watson, Shaun R. D.
    Welgampola, Miriam S.
    [J]. OTOLOGY & NEUROTOLOGY, 2022, 43 (04) : E489 - E496
  • [39] Predictive Value of Electrocochleography for Determining Hearing Outcomes in Meniere's Disease
    Moon, Il Joon
    Park, Ga Young
    Choi, Jeesun
    Cho, Yang-Sun
    Hong, Sung Hwa
    Chung, Won-Ho
    [J]. OTOLOGY & NEUROTOLOGY, 2012, 33 (02) : 204 - 210
  • [40] Surgical management of Meniere's disease in the era of gentamicin
    Kaylie, DM
    Jackson, CG
    Gardner, EK
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2005, 132 (03) : 443 - 450